Patents/Assignees

Cardiff Oncology, Inc.

4 patents in portfolio

US12606616utility2026
PLK1 Inhibitor in Combination with Anti-angiogenics for Treating Metastatic Cancer
0 cites
US12263173utility2025
PLK1 Inhibitor in Combination with Anti-angiogenics for Treating Metastatic Cancer
0 cites
US12144813utility2024
PLK1 Inhibitor in Combination with Anti-angiogenics for Treating Metastatic Cancer
0 cites
US11957677utility2024
Cancer Treatment Using FGFR Inhibitors and PLK1 Inhibitors
0 cites